Welcome to the Fall 2017 edition of Oncology & Hematology Review (US). This edition of the journal is opened with a letter from our Editor in Chief, Shaji Kumar, which is followed by and expert interview with Dr Suresh Ramalingam, on immune therapies in NSCLC, and an editorial on prostate cancer screening from Monique Roobol.
The journal covers a broad range of topics and includes reviews on adult acute lymphoblastic leukemia, and myelodysplastic syndrome, from Xavier Thomas and Alcedo et al., respectively. Kinsey and Salma review current therapies for, and the future of, metastatic uveal melanoma; and Hendifar and Bullock review the use of PEHPG20 in the treatment of pancreatic ductal adenocarcinoma. Dr Alan Koletsky discusses the therapeutic landscape in metastatic prostate cancer, which is followed by a review on the treatment approach for adrenal oligometastases secondary to NSCLC.
We hope you enjoy this edition of Oncology & Hematology Review (US), and find it useful for your practice. We look forward to bringing you our Spring 2018 edition, and plenty of topical content in the meantime.